Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms

NCT00289926 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Quality of Life
Menopausal Syndrome
Libido Disorder

Interventions

DRUG: dehydroepiandrosterone
DRUG: placebo

Sponsor

Monash University